I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 3 studies | 20% ± 5% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 3 studies | 20% ± 5% |
Insufficient scRNA-seq data for expression of TADA2B at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| adrenal gland | 100% | 3182.70 | 258 / 258 | 100% | 24.14 | 230 / 230 |
| breast | 100% | 2251.46 | 459 / 459 | 100% | 32.34 | 1118 / 1118 |
| esophagus | 100% | 2372.70 | 1445 / 1445 | 100% | 15.45 | 183 / 183 |
| kidney | 100% | 2151.18 | 89 / 89 | 100% | 23.13 | 901 / 901 |
| liver | 100% | 1674.47 | 226 / 226 | 100% | 14.29 | 406 / 406 |
| pancreas | 100% | 2360.36 | 328 / 328 | 100% | 19.51 | 178 / 178 |
| prostate | 100% | 2366.44 | 245 / 245 | 100% | 32.95 | 502 / 502 |
| stomach | 100% | 2188.50 | 359 / 359 | 100% | 16.58 | 286 / 286 |
| thymus | 100% | 2155.22 | 653 / 653 | 100% | 27.44 | 605 / 605 |
| lung | 100% | 1779.47 | 577 / 578 | 100% | 17.75 | 1155 / 1155 |
| intestine | 100% | 2463.87 | 966 / 966 | 100% | 17.24 | 526 / 527 |
| skin | 100% | 2142.85 | 1809 / 1809 | 100% | 22.37 | 471 / 472 |
| ovary | 100% | 2440.01 | 180 / 180 | 100% | 15.41 | 429 / 430 |
| brain | 100% | 1696.02 | 2630 / 2642 | 100% | 25.18 | 705 / 705 |
| bladder | 100% | 2219.38 | 21 / 21 | 99% | 16.63 | 501 / 504 |
| uterus | 100% | 2196.57 | 170 / 170 | 99% | 17.05 | 454 / 459 |
| adipose | 100% | 1913.06 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 2278.78 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 24.14 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 20.06 | 29 / 29 |
| muscle | 100% | 5751.96 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2626.71 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 16.49 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 13.76 | 1 / 1 |
| heart | 99% | 2095.71 | 850 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 98% | 2354.74 | 915 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0043484 | Biological process | regulation of RNA splicing |
| GO_0006282 | Biological process | regulation of DNA repair |
| GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
| GO_0006338 | Biological process | chromatin remodeling |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0000124 | Cellular component | SAGA complex |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0070461 | Cellular component | SAGA-type complex |
| GO_0005634 | Cellular component | nucleus |
| GO_0003713 | Molecular function | transcription coactivator activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0008270 | Molecular function | zinc ion binding |
| GO_0003682 | Molecular function | chromatin binding |
| Gene name | TADA2B |
| Protein name | Transcriptional adapter 2-beta (ADA2-like protein beta) (ADA2-beta) Transcriptional adaptor 2B |
| Synonyms | ADA2B |
| Description | FUNCTION: Coactivates PAX5-dependent transcription together with either SMARCA4 or GCN5L2. . |
| Accessions | ENST00000510704.1 ENST00000310074.8 [Q86TJ2-1] ENST00000512388.1 [Q86TJ2-2] ENST00000515646.1 [Q86TJ2-3] D6RJ05 D6RC20 Q86TJ2 ENST00000506692.1 |
